scispace - formally typeset
A

Anthony A. Amato

Researcher at Brigham and Women's Hospital

Publications -  930
Citations -  71207

Anthony A. Amato is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Muon spin spectroscopy & LIGO. The author has an hindex of 105, co-authored 911 publications receiving 57881 citations. Previous affiliations of Anthony A. Amato include Helsinki Institute of Physics & University of Rochester Medical Center.

Papers
More filters
Journal ArticleDOI

Distinctive patterns of microRNA expression in primary muscular disorders

TL;DR: In this article, the authors search for miRNAs regulated during the degenerative process of muscle to gain insight into the specific regulation of genes that are disrupted in pathological muscle conditions, including Duchenne muscular dystrophy and Miyoshi myopathy.
Journal ArticleDOI

Binary Black Hole Population Properties Inferred from the First and Second Observing Runs of Advanced LIGO and Advanced Virgo

B. P. Abbott, +1218 more
TL;DR: In this paper, the mass, spin, and redshift distributions of binary black hole (BBH) mergers with LIGO and Advanced Virgo observations were analyzed using phenomenological population models.
Journal ArticleDOI

Tests of General Relativity with GW170817

B. P. Abbott, +1240 more
TL;DR: In this paper, the authors place constraints on the dipole radiation and possible deviations from GR in the post-Newtonian coefficients that govern the inspiral regime of a binary neutron star inspiral.
Journal ArticleDOI

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, +623 more
- 01 Dec 2017 - 
TL;DR: A phase 3, randomised, double-blind, placebo-controlled, multicentre study in 76 hospitals and specialised clinics across North America, Latin America, Europe, and Asia to assess the efficacy and safety of eculizumab in patients with refractory myasthenia gravis.
Journal ArticleDOI

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

TL;DR: A clinical scheme for approaching the chronic acquired demyelinating polyneuropathies that leads to a rational use of supportive laboratory studies and treatment options is described and new diagnostic criteria for CIDP are proposed that more accurately reflect current clinical practice.